854P Final results of a phase II study of tipifarnib in chronic myelomonocytic leukemia (CMML) and other myelodysplastic/myeloproliferative neoplasms (MDS/MPN).
Saved in:
| Title: | 854P Final results of a phase II study of tipifarnib in chronic myelomonocytic leukemia (CMML) and other myelodysplastic/myeloproliferative neoplasms (MDS/MPN). |
|---|---|
| Authors: | Patnaik, M.M.1 (AUTHOR), Sekeres, M.A.2 (AUTHOR), DeZern, A.3 (AUTHOR), Luger, S.4 (AUTHOR), Sproat, L.5 (AUTHOR), Bejar, R.6 (AUTHOR), Hobbs, G.7 (AUTHOR), Roboz, G.J.8 (AUTHOR), Leoni, M.9 (AUTHOR), Martell, B.9 (AUTHOR), Padron, E.10 (AUTHOR) |
| Source: | Annals of Oncology. 2021 Supplement 5, Vol. 32, pS783-S784. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2021.08.147 |
